chlorpromazine has been researched along with Cognition Disorders in 37 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine may be of benefit in anorexia nervosa by causing a reduction in anorexic rumination." | 9.11 | Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. ( Beumont, P; Birmingham, CL; Chapman, L; Mondraty, N; Sundakov, V; Touyz, S, 2005) |
| "Olanzapine may be of benefit in anorexia nervosa by causing a reduction in anorexic rumination." | 5.11 | Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. ( Beumont, P; Birmingham, CL; Chapman, L; Mondraty, N; Sundakov, V; Touyz, S, 2005) |
| " The long-term administration of neuroleptics in severe cases of SDAT caused a significant increase of SLI (p < 0." | 1.30 | Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. ( Cramer, H; Hamann, G; Reuner, C; Schimrigk, K; Strittmatter, M; Strubel, D, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (32.43) | 18.7374 |
| 1990's | 5 (13.51) | 18.2507 |
| 2000's | 15 (40.54) | 29.6817 |
| 2010's | 5 (13.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naeem, S | 1 |
| Ikram, R | 1 |
| Khan, SS | 1 |
| Rao, SS | 1 |
| Wobrock, T | 1 |
| Falkai, P | 1 |
| Schneider-Axmann, T | 1 |
| Hasan, A | 1 |
| Galderisi, S | 1 |
| Davidson, M | 1 |
| Kahn, RS | 1 |
| Derks, EM | 1 |
| Boter, H | 1 |
| Rybakowski, JK | 1 |
| Libiger, J | 1 |
| Dollfus, S | 1 |
| López-Ibor, JJ | 1 |
| Peuskens, J | 1 |
| Hranov, LG | 1 |
| Gaebel, W | 1 |
| Fleischhacker, WW | 1 |
| Rodewald, K | 1 |
| Holt, DV | 1 |
| Rentrop, M | 1 |
| Roesch-Ely, D | 1 |
| Liebrenz, M | 1 |
| Funke, J | 1 |
| Weisbrod, M | 1 |
| Kaiser, S | 1 |
| Chang, WC | 1 |
| Chan, TC | 1 |
| Chiu, SS | 1 |
| Hui, CL | 1 |
| Chan, SK | 1 |
| Lee, EH | 1 |
| Chen, EY | 1 |
| Forbes, NF | 1 |
| Carrick, LA | 1 |
| McIntosh, AM | 1 |
| Lawrie, SM | 1 |
| Nemoto, T | 1 |
| Yamazawa, R | 1 |
| Kobayashi, H | 1 |
| Fujita, N | 1 |
| Chino, B | 1 |
| Fujii, C | 1 |
| Kashima, H | 1 |
| Rassovsky, Y | 1 |
| Green, MF | 1 |
| Mizuno, M | 1 |
| Iakimova, G | 1 |
| Passerieux, C | 1 |
| Denhière, G | 1 |
| Laurent, JP | 1 |
| Vistoli, D | 1 |
| Vilain, J | 1 |
| Hardy-Baylé, MC | 1 |
| Shean, G | 1 |
| Burnett, T | 1 |
| Eckman, FS | 1 |
| Youn, T | 1 |
| Park, HJ | 1 |
| Kim, JJ | 1 |
| Kim, MS | 1 |
| Kwon, JS | 1 |
| Perlstein, WM | 1 |
| Dixit, NK | 1 |
| Carter, CS | 1 |
| Noll, DC | 1 |
| Cohen, JD | 1 |
| Hagh-Shenas, H | 1 |
| Toobai, S | 1 |
| Makaremi, A | 1 |
| Martínez-Arán, A | 1 |
| Vieta, E | 1 |
| Colom, F | 1 |
| Torrent, C | 1 |
| Sánchez-Moreno, J | 1 |
| Reinares, M | 1 |
| Benabarre, A | 1 |
| Goikolea, JM | 1 |
| Brugué, E | 1 |
| Daban, C | 1 |
| Salamero, M | 1 |
| Peer, JE | 1 |
| Rothmann, TL | 1 |
| Penrod, RD | 1 |
| Penn, DL | 1 |
| Spaulding, WD | 2 |
| Mondraty, N | 1 |
| Birmingham, CL | 1 |
| Touyz, S | 1 |
| Sundakov, V | 1 |
| Chapman, L | 1 |
| Beumont, P | 1 |
| Schuepbach, D | 1 |
| Hill, SK | 1 |
| Sanders, RD | 1 |
| Hell, D | 1 |
| Keshavan, MS | 1 |
| Sweeney, JA | 1 |
| Silverstein, SM | 1 |
| Menditto, AA | 1 |
| Savitz, A | 1 |
| Liberman, RP | 1 |
| Berten, S | 1 |
| Starobin, H | 1 |
| Watzke, S | 1 |
| Brieger, P | 1 |
| Kuss, O | 1 |
| Schoettke, H | 1 |
| Wiedl, KH | 1 |
| Singh, D | 1 |
| Forlano, R | 1 |
| Athey, R | 1 |
| Folstein, S | 1 |
| Folstein, M | 1 |
| King, DJ | 1 |
| Delahunty, A | 1 |
| Morice, R | 1 |
| Frost, B | 1 |
| Strittmatter, M | 1 |
| Cramer, H | 1 |
| Reuner, C | 1 |
| Strubel, D | 1 |
| Hamann, G | 1 |
| Schimrigk, K | 1 |
| Ikebuchi, E | 1 |
| Nakagome, K | 1 |
| Takahashi, N | 1 |
| Evans, JD | 1 |
| Negron, AE | 1 |
| Palmer, BW | 1 |
| Paulsen, JS | 1 |
| Heaton, RK | 1 |
| Jeste, DV | 1 |
| Oades, RD | 1 |
| Rao, ML | 1 |
| Bender, S | 1 |
| Sartory, G | 1 |
| Müller, BW | 1 |
| Darvesh, S | 1 |
| MacKnight, C | 1 |
| Rockwood, K | 1 |
| Kay, SR | 1 |
| Singh, MM | 1 |
| Kolakowska, T | 1 |
| Williams, AO | 1 |
| Ardern, M | 1 |
| Reveley, MA | 1 |
| Jambor, K | 1 |
| Gelder, MG | 1 |
| Mandelbrote, BM | 1 |
| Van Sweden, B | 1 |
| Franzén, G | 1 |
| Raskin, A | 1 |
| Minde, K | 1 |
| Weiss, G | 1 |
| Mendelson, N | 1 |
| Zolotnitskii, RI | 1 |
| Kutsenok, BM | 1 |
| Gastev, MD | 1 |
| Cramond, WA | 1 |
| Zlotlow, M | 1 |
| Abenson, MH | 1 |
| DeVito, RA | 1 |
| Sykes, DE | 1 |
| McDonald, EK | 1 |
| Larson, JL | 1 |
| Smith, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Changes in Serum miRNA and BDNF Levels in Bipolar II Depression Treated by Theta-burst Stimulation: A Randomized Sham-controlled Exploratory Study[NCT04998097] | 60 participants (Anticipated) | Interventional | 2022-05-23 | Recruiting | |||
| Effectiveness Trial of Attention Shaping for Schizophrenia[NCT00391677] | 120 participants (Actual) | Interventional | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for chlorpromazine and Cognition Disorders
| Article | Year |
|---|---|
Working memory in schizophrenia: a meta-analysis.
Topics: Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Humans; Memory; Memory Disorders; Psychol | 2009 |
Psychomotor impairment and cognitive disturbances induced by neuroleptics.
Topics: Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Eye Movements; Humans; Neurolo | 1994 |
5 trials available for chlorpromazine and Cognition Disorders
| Article | Year |
|---|---|
Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Antisocial Personality Disorder; Chlorpromazine; | 2013 |
Predictors for improvement of problem-solving during cognitive remediation for patients with Schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Cognitive Behavioral Therapy; Fema | 2014 |
Cognitive training for divergent thinking in schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Cognitive Behavioral Therapy; Fema | 2009 |
Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cognition Disorders; | 2005 |
Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Cognitive Behavioral Th | 2009 |
30 other studies available for chlorpromazine and Cognition Disorders
| Article | Year |
|---|---|
NSAIDs ameliorate cognitive and motor impairment in a model of parkinsonism induced by chlorpromazine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Behavior, Animal; Chlorproma | 2017 |
Self-perceived cognitive functioning and its relationship with objective performance in first-episode schizophrenia: the Subjective Cognitive Impairment Scale.
Topics: Adolescent; Adult; Antipsychotic Agents; Asian People; Chlorpromazine; Cognition; Cognition Disorder | 2015 |
The influence of idiomatic salience during the comprehension of ambiguous idioms by patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Comprehensio | 2010 |
Symptoms of schizophrenia and neurocognitive test performance.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Female; Follow-Up Stud | 2002 |
Altered hemispheric asymmetry and positive symptoms in schizophrenia: equivalent current dipole of auditory mismatch negativity.
Topics: Adult; Antipsychotic Agents; Auditory Perceptual Disorders; Chlorpromazine; Cognition Disorders; Ele | 2003 |
Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Delayed-Action Preparations; Femal | 2003 |
Selective, sustained, and shift in attention in patients with diagnoses of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Diagnostic | 2002 |
Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Dysthymic Disorde | 2004 |
Social cognitive bias and neurocognitive deficit in paranoid symptoms: evidence for an interaction effect and changes during treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Cogni | 2004 |
Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Diagnostic and Statist | 2004 |
A longitudinal study of learning potential and rehabilitation outcome in schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Diagnostic and S | 2008 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Choline | 2008 |
Diagnosis and treatment of Huntington's disease.
Topics: Affective Symptoms; Amitriptyline; Chlorpromazine; Cognition Disorders; Counseling; Deglutition Diso | 1981 |
Specific cognitive flexibility rehabilitation in schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain Diseases; Chlorpromazine; Cognition Disorders; Cognitive Behavior | 1993 |
Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Chlorpromazine; Chromatography, High Pressure Liquid; | 1997 |
How do early stages of information processing influence social skills in patients with schizophrenia?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Dose-Response Relationship, Drug; | 1999 |
Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Cognition Disor | 1999 |
Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy.
Topics: Adult; Antipsychotic Agents; Attention; Case-Control Studies; Chlorpromazine; Cognition Disorders; C | 2000 |
Butyrylcholinesterase and cognitive function.
Topics: Adult; Brain; Butyrylcholinesterase; Chlorpromazine; Cholinergic Antagonists; Cognition Disorders; D | 2001 |
Cognitive abnormality in schizophrenia: a dual-process model.
Topics: Adolescent; Adult; Arousal; Attention; Chlorpromazine; Cognition Disorders; Color Perception; Concep | 1979 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Femal | 1985 |
Toxic "ictal" confusion in middle age: treatment with benzodiazepines.
Topics: Adult; Benzodiazepinones; Chlorpromazine; Cimetidine; Clonazepam; Cognition Disorders; Confusion; Di | 1985 |
Serum cortisol in chronic schizophrenia. A study of the adrenocortical response to intravenously administered insulin and ACTH.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Age Factors; Aged; Amitriptyline; Blood Glucose; Chlorp | 1971 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |
A 5-year follow-up study of 91 hyperactive school children.
Topics: Adolescent; Child; Chlorpromazine; Cognition Disorders; Dextroamphetamine; Female; Follow-Up Studies | 1972 |
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall | 1969 |
Organic psychosis.
Topics: Acute Disease; Affective Symptoms; Bender-Gestalt Test; Chlordiazepoxide; Chlorpromazine; Chronic Di | 1968 |
Temporal lobe "spike focus" associated with confusion, complete amnesia and fugues in a paranoid schizophrenic.
Topics: Adult; Amnesia; Chlorpromazine; Cognition Disorders; Dissociative Disorders; Electroencephalography; | 1968 |
Drug withdrawal in male and female chronic schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Cognition Disorders; Female; Humans; Male; Paranoid Disorders; Phen | 1969 |
SKF 14336 versus schizophrenia.
Topics: Acridines; Adult; Chlorpromazine; Cognition Disorders; Female; Humans; Male; Middle Aged; Perceptual | 1969 |